Novartis’ Sauer Updates on AMD Trial, Sees Bright Future for Ophthalmology Innovation

Dirk Sauer, PhD, global development unit head of ophthalmology, lays out the next steps for Novartis’ potential AMD blockbuster. He also shares his views on ophthalmology’s innovative future.